Dianthus Therapeutics (DNTH) Other financing activities (2018 - 2024)

Dianthus Therapeutics' quarterly Other financing activities came in at $2.2 million in Q2 2024, down 81.94% quarter-over-quarter from $12.4 million in Q1 2024.

Dianthus Therapeutics has reported Other financing activities for 5 years, with the latest figure at $2.2 million in Q2 2024.

  • For the quarter ending Q2 2024, Other financing activities changed N/A year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2025 stood at $2.2 million (down 81.94% YoY), and the FY2024 full-year result was $14.7 million, changed N/A from the prior year.
  • Other financing activities for Q2 2024 stood at $2.2 million, down from $12.4 million in the prior quarter.
  • The five-year high for Other financing activities was $12.4 million in Q1 2024, with the low at $60000.0 in Q4 2020.
  • Average Other financing activities over 3 years is $3.0 million, with a median of $237000.0 recorded in 2020.
  • Year-over-year, Other financing activities surged 46.3% in 2020 and declined 6.33% in 2021.
  • Tracing DNTH's Other financing activities over 3 years: stood at $60000.0 in 2020, then jumped by 270.0% to $222000.0 in 2021, then surged by 910.36% to $2.2 million in 2024.
  • The last three Other financing activities figures came in at $2.2 million (Q2 2024), $12.4 million (Q1 2024), and $222000.0 (Q3 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Dianthus Therapeutics 4.02 Bn 3.62 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2024 2.24 Mn
Jun 30, 2024 2.24 Mn
Mar 31, 2024 12.42 Mn
Mar 31, 2024 12.42 Mn
Sep 30, 2021 222,000.00
Sep 30, 2021 222,000.00
Dec 31, 2020 60,000.00
Dec 31, 2020 60,000.00
Sep 30, 2020 237,000.00
Sep 30, 2020 237,000.00
Sep 30, 2019 162,000.00
Sep 30, 2019 162,000.00
Dec 31, 2018 476,000.00
Dec 31, 2018 476,000.00
Sep 30, 2018 760,000.00
Sep 30, 2018 760,000.00
Jun 30, 2018 1.76 Mn
Jun 30, 2018 1.76 Mn
Mar 31, 2018 166,000.00
Mar 31, 2018 166,000.00